Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disorder of unknown origin and
the most common interstitial lung disease. It progresses with the recruitment of fibroblasts …

Pulmonary fibrosis is a progressive and intractable lung disease with fibrotic features that
affects alveoli elasticity, which leading to higher rates of hospitalization and mortality …

Nonalcoholic fatty liver disease (NAFLD) has become a worldwide epidemic and a major
public health problem, with a prevalence of approximately 25%. The pathogenesis of …

Fibrotic cardiac diseases are characterized by myocardial fibrosis that results in maladaptive
cardiac remodeling. Cardiac fibroblasts (CFs) are the main cell type responsible for fibrosis …

Cardiac fibrosis is characterized by the excessive deposition of extracellular matrix in the
myocardium with cardiac fibroblast activation, leading to chronic cardiac remodeling and …

Idiopathic pulmonary fibrosis is a progressive lung disease of unknown etiology
characterized by distorted distal lung architecture, inflammation, and fibrosis. Several lung …

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease of
unknown etiology. The emerging evidence demonstrates that metabolic homeostatic …

Introduction: Systemic sclerosis (SSc) is a chronic autoimmune disease, marked by an
unpredictable course, high morbidity, and increased mortality risk that occurs especially in …

Idiopathic pulmonary fibrosis (IPF) is a chronic inflammatory disease destroying lungs
irreversibly with high mortality rates. There are challenges in diagnosing IPF and treating it …

Immune cells are essential for initiating and developing the fibrotic process by releasing
cytokines and growth factors that activate fibroblasts and promote extracellular matrix …